General Screening and Anticoagulant Testing
Broad assay menu for tailored testing
HemosIL PT reagents offer consistent performance sensitivity to enable optimal monitoring of oral anticoagulant therapy and evaluation of the extrinsic coagulation pathway. Highly stable and always consistent for moderate to high sensitivity. HemosIL APTT reagents enable optimal monitoring of therapeutic coagulation inhibitors and screening of the intrinsic coagulation pathyway with excellent sensitivity and lot-to-lot consistency. The General Screening Panel also includes Fibrinogen assays to assess bleeding risk in patients with unexplained prolonged PT or APTT results.
Consistency, test after test, for optimal efficiency.
Calcium Chloride 0.025 M
LMW Heparin Controls
PT-Fibrinogen HS Plus
Q.F.A. Thrombin 2ml
Q.F.A. Thrombin 5ml
RecombiPlasTin 2G 20mL
RecombiPlasTin 2G 8mL
UF Heparin Controls
* Not 510(k) cleared. Not available in all countries.
** Chemiluminescent technology assay. For Use on ACL AcuStar Hemostasis Testing System.